296 related articles for article (PubMed ID: 24636762)
1. Frequency and causes of hospitalization in older compared to younger adults with type 2 diabetes in the United States: a retrospective, claims-based analysis.
Fu H; Curtis BH; Xie W; Festa A; Schuster DP; Kendall DM
J Diabetes Complications; 2014; 28(4):477-81. PubMed ID: 24636762
[TBL] [Abstract][Full Text] [Related]
2. Identifying factors associated with hypoglycemia-related hospitalizations among elderly patients with T2DM in the US: a novel approach using influential variable analysis.
Fu H; Xie W; Curtis B; Schuster D
Curr Med Res Opin; 2014 Sep; 30(9):1787-93. PubMed ID: 24810150
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
[TBL] [Abstract][Full Text] [Related]
4. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies.
Xie L; Wei W; Pan C; Baser O
J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434
[TBL] [Abstract][Full Text] [Related]
5. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
8. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia-related emergency department visits and hypoglycemia-related hospitalizations among new users of antidiabetes treatments.
Moisan J; Breton MC; Villeneuve J; Grégoire JP
Can J Diabetes; 2013 Jun; 37(3):143-9. PubMed ID: 24070836
[TBL] [Abstract][Full Text] [Related]
10. Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients.
Brodovicz KG; Mehta V; Zhang Q; Zhao C; Davies MJ; Chen J; Radican L; Engel SS
Curr Med Res Opin; 2013 Feb; 29(2):101-7. PubMed ID: 23198978
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization.
Dalal MR; Kazemi M; Ye F; Xie L
Adv Ther; 2017 Sep; 34(9):2083-2092. PubMed ID: 28779282
[TBL] [Abstract][Full Text] [Related]
12. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemia in hospitalized patients treated with sulfonylureas.
Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
[TBL] [Abstract][Full Text] [Related]
14. [Hypoglycemia in the elderly with diabetes mellitus].
Avila-Fematt FM; Montaña-Alvarez M
Rev Invest Clin; 2010; 62(4):366-74. PubMed ID: 21222316
[TBL] [Abstract][Full Text] [Related]
15. The economic effect of hypoglycemia in a health plan.
Heaton A; Martin S; Brelje T
Manag Care Interface; 2003 Jul; 16(7):23-7. PubMed ID: 12908214
[TBL] [Abstract][Full Text] [Related]
16. Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis.
Lee LJ; Yu AP; Johnson SJ; Birnbaum HG; Atanasov P; Buesching DP; Jackson JA; Davidson JA
Diabetes Res Clin Pract; 2010 Jan; 87(1):108-16. PubMed ID: 19896233
[TBL] [Abstract][Full Text] [Related]
17. Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment.
Burke J; Kovacs B; Borton L; Sander S
Postgrad Med; 2012 Mar; 124(2):77-91. PubMed ID: 22437218
[TBL] [Abstract][Full Text] [Related]
18. Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials.
Asche CV; Luo W; Aagren M
Curr Med Res Opin; 2013 Oct; 29(10):1287-96. PubMed ID: 23865725
[TBL] [Abstract][Full Text] [Related]
19. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
Dailey G; Strange P
Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of the older patient with type 2 diabetes mellitus.
Neumiller JJ; Setter SM
Am J Geriatr Pharmacother; 2009 Dec; 7(6):324-42. PubMed ID: 20129254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]